These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 23817958)

  • 1. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.
    Gieseke F; Kruchen A; Tzaribachev N; Bentzien F; Dominici M; Müller I
    Eur J Immunol; 2013 Oct; 43(10):2741-9. PubMed ID: 23817958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
    Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
    Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
    Sioud M; Mobergslien A; Boudabous A; Fløisand Y
    Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the role of TNF-α in mesenchymal stromal cell-mediated immunosuppression.
    Pistoia V; Raffaghello L
    Eur J Immunol; 2014 Feb; 44(2):352-6. PubMed ID: 24435827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secreted galectin-3 as a possible biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stromal cells.
    Liu GY; Xu Y; Li Y; Wang LH; Liu YJ; Zhu D
    Cytotherapy; 2013 Oct; 15(10):1208-17. PubMed ID: 23850421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
    Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
    Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
    Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
    Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions.
    Najar M; Raicevic G; Id Boufker H; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Exp Hematol; 2010 Oct; 38(10):922-32. PubMed ID: 20570633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells.
    Hemeda H; Jakob M; Ludwig AK; Giebel B; Lang S; Brandau S
    Stem Cells Dev; 2010 May; 19(5):693-706. PubMed ID: 20067407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory properties of colonic mesenchymal stem cells.
    Hu J; Zhang X; Zhou L; Zhang Y
    Immunol Lett; 2013; 156(1-2):23-9. PubMed ID: 24060593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of galectin-1 in regulation of umbilical cord mesenchymal stem cells on T cells of rheumatoid arthritis].
    Sun L; An Z; Li CH; Liu R; Zhao JX; Liu XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):964-969. PubMed ID: 27987498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M; Yamahara K; Ishikane S; Harada K; Tsuda H; Otani K; Taguchi A; Miyazato M; Katsuragi S; Yoshimatsu J; Kodama M; Kangawa K; Ikeda T
    J Mol Cell Cardiol; 2012 Sep; 53(3):420-8. PubMed ID: 22796574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury.
    Ryu KH; Kim SY; Kim YR; Woo SY; Sung SH; Kim HS; Jung SC; Jo I; Park JW
    Exp Cell Res; 2014 Aug; 326(1):143-54. PubMed ID: 24954408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1.
    Sheng H; Wang Y; Jin Y; Zhang Q; Zhang Y; Wang L; Shen B; Yin S; Liu W; Cui L; Li N
    Cell Res; 2008 Aug; 18(8):846-57. PubMed ID: 18607390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9.
    Fan J; Tang X; Wang Q; Zhang Z; Wu S; Li W; Liu S; Yao G; Chen H; Sun L
    Stem Cell Res Ther; 2018 Sep; 9(1):237. PubMed ID: 30223894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.